Development and validation of a nomogram with an epigenetic signature for predicting survival in patients with lung adenocarcinoma
Figure 3.GSEA and GSVA. Top 5 representative (A) GO terms and (B) enriched KEGG pathways between high- and low-risk groups. (C) GSVA of the high- and low-risk clusters.